Location History:
- Shanghai, CN (2015 - 2017)
- Shanghai, KR (2018)
Company Filing History:
3 out of 2,405 
3 out of 55 Years Active: 2015-2018
Title: Xiaobang Duan: Innovator in RORgammaT Inhibitors
Introduction
Xiaobang Duan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of RORgammaT inhibitors. With a total of 3 patents, his work focuses on innovative compounds that have the potential to treat various diseases.
Latest Patents
Duan's latest patents include groundbreaking inventions related to RORgammaT inhibitors. The present invention pertains to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. These compounds can be utilized in the treatment of RORgammaT-mediated diseases or conditions. His work in this area is crucial for advancing therapeutic options for patients suffering from these ailments.
Career Highlights
Throughout his career, Xiaobang Duan has worked with notable companies such as Merck Sharp & Dohme Corporation and Merck Sharp & Dohme B.V. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in pharmaceutical research.
Collaborations
Duan has collaborated with esteemed colleagues, including Willem Frederik Johan Karstens and Mario Van Der Stelt. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.
Conclusion
Xiaobang Duan is a distinguished inventor whose work on RORgammaT inhibitors is paving the way for new treatments in medicine. His contributions to the pharmaceutical industry are invaluable and demonstrate the importance of innovation in addressing health challenges.